The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Saved in:
Bibliographic Details
Title: The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Authors: Steinberg MH; Department of Medicine, Boston University School of Medicine, Boston Medical Center, Massachusetts, USA. mhsteinb@bu.edu , McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA
Corporate Authors: Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up
Source: American journal of hematology [Am J Hematol] 2010 Jun; Vol. 85 (6), pp. 403-8.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-8652
DOI:10.1002/ajh.21699